212 related articles for article (PubMed ID: 34018874)
1. Alzheimer's Disease: Innovative Therapeutic Approaches Based on Peptides and Nanoparticles.
Mota IFL; de Lima LS; Santana BM; Gobbo GAM; Bicca JVML; Azevedo JRM; Veras LG; Taveira RAA; Pinheiro GB; Mortari MR
Neuroscientist; 2023 Feb; 29(1):78-96. PubMed ID: 34018874
[TBL] [Abstract][Full Text] [Related]
2. A review on Alzheimer's disease pathophysiology and its management: an update.
Kumar A; Singh A; Ekavali
Pharmacol Rep; 2015 Apr; 67(2):195-203. PubMed ID: 25712639
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease and its treatment by different approaches: A review.
Srivastava S; Ahmad R; Khare SK
Eur J Med Chem; 2021 Apr; 216():113320. PubMed ID: 33652356
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiological Aspects and Therapeutic Armamentarium of Alzheimer's Disease: Recent Trends and Future Development.
Dave BP; Shah YB; Maheshwari KG; Mansuri KA; Prajapati BS; Postwala HI; Chorawala MR
Cell Mol Neurobiol; 2023 Nov; 43(8):3847-3884. PubMed ID: 37725199
[TBL] [Abstract][Full Text] [Related]
5. Disease-modifying drugs in Alzheimer's disease.
Ghezzi L; Scarpini E; Galimberti D
Drug Des Devel Ther; 2013 Dec; 7():1471-8. PubMed ID: 24353405
[TBL] [Abstract][Full Text] [Related]
6. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
7. Cognitive symptoms of Alzheimer's disease: clinical management and prevention.
Joe E; Ringman JM
BMJ; 2019 Dec; 367():l6217. PubMed ID: 31810978
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Strategies Targeting Amyloid-β in Alzheimer's Disease.
Pinheiro L; Faustino C
Curr Alzheimer Res; 2019; 16(5):418-452. PubMed ID: 30907320
[TBL] [Abstract][Full Text] [Related]
9. Application of optogenetic Amyloid-β distinguishes between metabolic and physical damages in neurodegeneration.
Lim CH; Kaur P; Teo E; Lam VYM; Zhu F; Kibat C; Gruber J; Mathuru AS; Tolwinski NS
Elife; 2020 Mar; 9():. PubMed ID: 32228858
[TBL] [Abstract][Full Text] [Related]
10. An update on drug treatment options of Alzheimer's disease.
Allgaier M; Allgaier C
Front Biosci (Landmark Ed); 2014 Jun; 19(8):1345-54. PubMed ID: 24896354
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy against amyloid pathology in Alzheimer's disease.
Galimberti D; Ghezzi L; Scarpini E
J Neurol Sci; 2013 Oct; 333(1-2):50-4. PubMed ID: 23299047
[TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapies for Alzheimer's disease: beyond cholinesterase inhibitors.
Tayeb HO; Yang HD; Price BH; Tarazi FI
Pharmacol Ther; 2012 Apr; 134(1):8-25. PubMed ID: 22198801
[TBL] [Abstract][Full Text] [Related]
13. Recent Advances Towards Diagnosis and Therapeutic Fingerprinting for Alzheimer's Disease.
Pradhan LK; Sahoo PK; Chauhan S; Das SK
J Mol Neurosci; 2022 Jun; 72(6):1143-1165. PubMed ID: 35553375
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease: review of current nanotechnological therapeutic strategies.
Baranowska-Wójcik E; Szwajgier D
Expert Rev Neurother; 2020 Mar; 20(3):271-279. PubMed ID: 31957510
[No Abstract] [Full Text] [Related]
15. Tacrine-Natural-Product Hybrids for Alzheimer's Disease Therapy.
Oset-Gasque MJ; Marco-Contelles JL
Curr Med Chem; 2020; 27(26):4392-4400. PubMed ID: 29611473
[TBL] [Abstract][Full Text] [Related]
16. Advancements in nanotherapeutics for Alzheimer's disease: current perspectives.
Harilal S; Jose J; Parambi DGT; Kumar R; Mathew GE; Uddin MS; Kim H; Mathew B
J Pharm Pharmacol; 2019 Sep; 71(9):1370-1383. PubMed ID: 31304982
[TBL] [Abstract][Full Text] [Related]
17. A Systematic Review on Donepezil-based Derivatives as Potential Cholinesterase Inhibitors for Alzheimer's Disease.
Korabecny J; Spilovska K; Mezeiova E; Benek O; Juza R; Kaping D; Soukup O
Curr Med Chem; 2019; 26(30):5625-5648. PubMed ID: 29768996
[TBL] [Abstract][Full Text] [Related]
18. Beyond immunotherapy: new approaches for disease modifying treatments for early Alzheimer's disease.
Ruthirakuhan M; Herrmann N; Suridjan I; Abraham EH; Farber I; Lanctôt KL
Expert Opin Pharmacother; 2016 Dec; 17(18):2417-2429. PubMed ID: 27825018
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
20. Contemporary anticholinesterase pharmaceuticals of natural origin and their synthetic analogues for the treatment of Alzheimer's disease.
Orhan G; Orhan I; Subutay-Oztekin N; Ak F; Sener B
Recent Pat CNS Drug Discov; 2009 Jan; 4(1):43-51. PubMed ID: 19149713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
